Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 64Breast Neoplasms 15Urinary Bladder Neoplasms 12Colorectal Neoplasms 9Carcinoma, Renal Cell 8Kidney Neoplasms 7Lung Neoplasms 6Neoplasm Metastasis 4Gastrointestinal Neoplasms 4Testicular Neoplasms 3Neoplasms 3Endometrial Neoplasms 3Urogenital Neoplasms 2Urinary Incontinence 2Head and Neck Neoplasms 2Erectile Dysfunction 2Disease 2Depression 2Carcinoma, Transitional Cell 2Anxiety Disorders 2Adenocarcinoma 2Wilms Tumor 1Vomiting 1Varicocele 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urogenital Abnormalities 1Urinary Bladder, Overactive 1Thyroid Neoplasms 1

Interventions

Gemcitabine 30Mitomycin 25BCG Vaccine 13Docetaxel 10Epirubicin 6erdafitinib 5durvalumab 5dodecyl maltoside 5Radiotherapy 5Cystoscopy 5apaziquone 4ALT-803 4tislelizumab 35-aminolevulinic acid hexyl ester 3viscum album peptide 2pembrolizumab 2disitamab vedotin 2avelumab 2VB4-845 2Therapeutics 2Imiquimod 2Hyaluronic Acid 2Administration, Intravesical 21-phenyl-3,3-dimethyltriazene 2vocimagene amiretrorepvec 1valrubicin 1tremelimumab 1toripalimab 1pirarubicin 1pemigatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Muscle Invasive Bladder Neoplasms × Surveys and Questionnaires × Genitourinary × Clear all
NCT05672615 2025-11-18

Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG

Johns Hopkins University

Recruiting
42 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡